Advertisement
The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

Thermal Gel Sheets

January 30, 2013 10:16 am | Fujipoly America Corp. | Product Releases | Comments

Fujipoly announces the availability of Sarcon® 50GR-Ae, an extremely soft 0.5-mm thick thermal interface material. The gel-like sheet compound is designed to efficiently transfer heat from its source to a nearby heat sink.

Adhesive Dispensers for Dual Barrel Cartridges

January 30, 2013 10:13 am | by MDT Staff | Product Releases | Comments

A full line of pneumatic bench top adhesive dispensers for standard dual barrel cartridges that eliminates operator fatigue and increases productivity is available from Ashby Cross Company.

St. Jude Medical Announces First Patient Enrollment in EnligHTN II Renal Denervation Study

January 30, 2013 9:00 am | by The Associated Press | News | Comments

ST. PAUL, Minn.--(BUSINESS WIRE)--Jan 30, 2013--St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced enrollment of the first patient in the EnligHTN II trial. This post-market clinical study will further evaluate the safety and efficacy of the EnligHTN ™ Renal...

Advertisement

SpectraScience and PENTAX Showcase WaveSTAT4 Optical Biopsy System at Arab Health 2013

January 30, 2013 9:00 am | by The Associated Press | News | Comments

SpectraScience, Inc. (OTCQB: SCIE), a San Diego based medical device company, today announced that in continuation of its distribution and sales efforts in Europe and the Middle East it is demonstrating its WavSTAT4 Optical Biopsy System at the 38th Annual Arab Health 2013 Exhibition and...

Medtronic Completes Strategic Investment in LifeTech Scientific Corporation

January 30, 2013 8:36 am | by The Associated Press | News | Comments

Strategic Alliance to Leverage Best of Both Companies to Reach Cardiovascular Patients in China and Other Emerging Markets MINNEAPOLIS and Shenzhen - January 30, 2013 - Medtronic, Inc. (NYSE:MDT)...

Medtronic Introduces the First and Only Neurostimulation Systems with CE Mark Approval for Full-Body MRI Scans

January 30, 2013 8:06 am | by The Associated Press | News | Comments

TOLOCHENAZ AND MINNEAPOLIS - January 30, 2013 - Medtronic, Inc. (NYSE: MDT) today introduced in Europe the first and only implantable neurostimulation systems indicated for use in the treatment of chronic back and/or leg pain that are designed for full-body Magnetic Resonance...

Organovo and OHSU Knight Cancer Institute Announce Collaboration in Cancer Research

January 30, 2013 8:05 am | by The Associated Press | News | Comments

Organovo Holdings, Inc. (OTCQX: ONVO) ("Organovo"), a creator and manufacturer of functional, three-dimensional human tissues for medical research and therapeutic applications, and the Knight Cancer Institute at Oregon Health & Science University (OHSU), a national leader in translational...

21st Century Oncology Introduces Comprehensive New Website

January 30, 2013 8:00 am | by The Associated Press | News | Comments

FORT MYERS, Fla.--(BUSINESS WIRE)--Jan 30, 2013--Radiation Therapy Services, Inc., also known as 21 st Century Oncology – the nation’s premier cancer treatment network and largest radiation therapy provider – is pleased to announce the launch of their new website. 21stCenturyOncology.com is now...

Advertisement

MyoKardia Appoints Industry Veteran Jonathan Fox, M.D., Ph.D., as Chief Medical Officer

January 30, 2013 8:00 am | by The Associated Press | News | Comments

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Jan 30, 2013--MyoKardia, Inc., a company focused on developing innovative therapeutics to treat genetic cardiovascular disease, today announced the appointment of Jonathan C. Fox, M.D., Ph.D., as Chief Medical Officer. In his role, Dr. Fox will be...

Svelte Medical Systems Announces Treatment of First Patient in the DIRECT II Drug-Eluting Stent Study

January 30, 2013 7:00 am | by The Associated Press | News | Comments

NEW PROVIDENCE, N.J.--(BUSINESS WIRE)--Jan 30, 2013--Svelte® Medical Systems today announced treatment of the first patient in the DIRECT II (Direct Implantation of Rapamycin-Eluting stents with bioabsorbable drug Carrier Technology) study at Middelheim Hospital in Antwerp, Belgium. DIRECT II is a...

Medgenics Launches First Clinical Trial in Hepatitis to Use INFRADURE Tissue Treatment

January 30, 2013 7:00 am | by The Associated Press | News | Comments

MISGAV, Israel & SAN FRANCISCO--(BUSINESS WIRE)--Jan 30, 2013--Medgenics, Inc. (NYSE MKT: MDGN and AIM: MEDU, MEDG) (the “Company”), the developer of a novel platform technology for the sustained production and delivery of therapeutic proteins in patients using their own tissue, announced...

Sunshine Heart Appoints Warren Watson to Board of Directors

January 30, 2013 5:15 am | by The Associated Press | News | Comments

Sunshine Heart, Inc. (NASDAQ: SSH) (ASX: SHC) today announced that Warren Watson has been appointed to the Company's Board of Directors. Mr. Watson replaces William Peters, MD, who steps down from the Board but continues on as Chief Technical Officer of Sunshine Heart. Both changes are...

IBM's Watson to Join Research Team at Rensselaer Polytechnic Institute

January 30, 2013 4:30 am | by IBM | News | Comments

IBM today announced it will provide a modified version an IBM Watson system to Rensselaer Polytechnic Institute, making it the first university to receive such a system. The arrival of the Watson system will enable new leading-edge research at Rensselaer, and afford faculty and students an opportunity to find new uses for Watson and deepen the systems’ cognitive capabilities. The firsthand experience of working on the system will also better position Rensselaer students as future leaders in the areas of Big Data, analytics, and cognitive computing. E-mail this page Save to del.icio.us Digg this

Inked and Regretful: Removing Tattoos

January 30, 2013 12:00 am | by U.S. Food & Drug Administration | News | Comments

That tattoo on your arm of a former flame - the one that seemed like a great idea years ago - is kind of embarrassing today. And your spouse is not too crazy about it either...

Class I Medical Device Recall: Vycor Medical, Inc., Vycor Viewsite Brain Access System (VBAS)

January 30, 2013 12:00 am | by U.S. Food & Drug Administration | News | Comments

Vycor Medical recalled its VBAS because an unidentified black fiber was found on the device. This product may cause serious adverse health consequences, including death.

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading